{
  "fileName": "EFTA01268400.pdf",
  "dataSet": "10",
  "documentType": "correspondence",
  "dateOriginal": "2017-10-10",
  "summary": "This document is an email correspondence discussing the cost basis of securities transferred. It includes details about specific securities, their purchase dates, quantities, and costs. The communication appears to be between individuals discussing financial matters related to asset transfers.",
  "persons": [
    {
      "name": "Paul Barrett",
      "role": "Sender",
      "category": "other",
      "context": "Paul Barrett is the sender of the email discussing the cost basis of securities.",
      "mentionCount": 1
    },
    {
      "name": "Richard Kahn",
      "role": "Recipient",
      "category": "other",
      "context": "Richard Kahn is the recipient of the email and is involved in discussions regarding the cost basis of transferred assets.",
      "mentionCount": 2
    }
  ],
  "connections": [
    {
      "person1": "Paul Barrett",
      "person2": "Richard Kahn",
      "relationshipType": "professional",
      "description": "Paul Barrett is communicating with Richard Kahn regarding financial matters related to asset transfers.",
      "strength": 3
    }
  ],
  "events": [],
  "locations": [
    "New York, NY"
  ],
  "keyFacts": [
    "The email discusses the cost basis of securities transferred, including specific details about the securities.",
    "Securities mentioned include Foundation Medicine Inc and Sangamo Therapeutics Inc.",
    "The email indicates a follow-up on questions regarding the cost basis for assets transferred.",
    "The document is marked as confidential."
  ],
  "analyzedAt": "2026-02-21T06:27:18.913Z"
}